HLB Pharmaceutical Co., Ltd (047920.KQ)

KRW 19320.0

(3.48%)

Net Debt Summary of HLB Pharmaceutical Co., Ltd

  • HLB Pharmaceutical Co., Ltd's latest annual net debt in 2023 was 18.96 Billion KRW , up 14.18% from previous year.
  • HLB Pharmaceutical Co., Ltd's latest quarterly net debt in 2024 Q2 was 2.32 Billion KRW , down -57.31% from previous quarter.
  • HLB Pharmaceutical Co., Ltd reported annual net debt of 16.6 Billion KRW in 2022, down -37.02% from previous year.
  • HLB Pharmaceutical Co., Ltd reported annual net debt of 26.36 Billion KRW in 2021, up 0.76% from previous year.
  • HLB Pharmaceutical Co., Ltd reported quarterly net debt of 5.45 Billion KRW for 2024 Q1, down -71.24% from previous quarter.
  • HLB Pharmaceutical Co., Ltd reported quarterly net debt of 17.74 Billion KRW for 2023 Q2, down -2.58% from previous quarter.

Annual Net Debt Chart of HLB Pharmaceutical Co., Ltd (2023 - 2016)

Historical Annual Net Debt of HLB Pharmaceutical Co., Ltd (2023 - 2016)

Year Net Debt Net Debt Growth
2023 18.96 Billion KRW 14.18%
2022 16.6 Billion KRW -37.02%
2021 26.36 Billion KRW 0.76%
2020 26.16 Billion KRW 150.31%
2019 10.45 Billion KRW 124.16%
2018 4.66 Billion KRW -51.44%
2017 9.6 Billion KRW -10.89%
2016 10.77 Billion KRW 0.0%

Peer Net Debt Comparison of HLB Pharmaceutical Co., Ltd

Name Net Debt Net Debt Difference
CMG Pharmaceutical Co., Ltd. 18.78 Billion KRW -0.943%
Celltrion Pharm, Inc. 142.81 Billion KRW 86.723%
Huons Global Co., Ltd. 13.26 Billion KRW -42.943%
DongKook Pharmaceutical Co., Ltd. 44.19 Billion KRW 57.096%
Enzychem Lifesciences Corporation -9.81 Billion KRW 293.221%
Humedix Co., Ltd. -77.54 Billion KRW 124.452%
Boditech Med Inc. -31.92 Billion KRW 159.391%
EuBiologics Co., Ltd. 4.88 Billion KRW -288.431%
FutureChem Co.,Ltd -4.93 Billion KRW 484.56%
Huons Co., Ltd. 73.9 Billion KRW 74.345%
BNC Korea Co., Ltd. -67.65 Billion KRW 128.028%
AptaBio Therapeutics Inc. -12.08 Billion KRW 256.934%